Page last updated: 2024-10-26

disulfiram and Benign Supratentorial Neoplasms

disulfiram has been researched along with Benign Supratentorial Neoplasms in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Disulfiram, a generic alcohol aversion drug, has promising preclinical activity against glioblastoma (GBM)."9.22A phase I study to repurpose disulfiram in combination with temozolomide to treat newly diagnosed glioblastoma after chemoradiotherapy. ( Campian, JL; DeWees, TA; Gujar, AD; Huang, J; Kim, AH; Lockhart, AC; Tran, DD; Tsien, CI, 2016)
"Disulfiram, a generic alcohol aversion drug, has promising preclinical activity against glioblastoma (GBM)."5.22A phase I study to repurpose disulfiram in combination with temozolomide to treat newly diagnosed glioblastoma after chemoradiotherapy. ( Campian, JL; DeWees, TA; Gujar, AD; Huang, J; Kim, AH; Lockhart, AC; Tran, DD; Tsien, CI, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, J1
Campian, JL1
Gujar, AD1
Tran, DD1
Lockhart, AC1
DeWees, TA1
Tsien, CI1
Kim, AH1

Trials

1 trial available for disulfiram and Benign Supratentorial Neoplasms

ArticleYear
A phase I study to repurpose disulfiram in combination with temozolomide to treat newly diagnosed glioblastoma after chemoradiotherapy.
    Journal of neuro-oncology, 2016, Volume: 128, Issue:2

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Chemoradiotherapy; Dacarbazine; Disulfiram

2016